Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

Lutein is more than an eye-protecting nutrient. New research reveals its role in brain health and disease prevention. Learn ...

The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...

The "Myopic Macular Degeneration (MMD) - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth understanding of Myopic Macular ...

Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...